TCL Archive Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation September 27, 1985
TCL Archive Two NCI Officials Leave for Industry, Academia: Carl Barrett Goes to Novartis, Karen Antman Named Provost and Dean at Boston University. February 18, 2005
TCL Archive Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s. October 26, 2001